To evaluate the Safety and efficacy of two Unani medicines in the treatment Scabies.
Phase 2
- Conditions
- Health Condition 1: null- Jarab(Scabies)Health Condition 2: B86- Scabies
- Registration Number
- CTRI/2015/02/005527
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
•Patients of either sex in the age group of 18 to 65 years.
•Presence of at least 3 of the following :
oPresence of Scabietic Lesions (papules, vesicles) at classical sites (Interdigital spaces etc)
oPresence of Classical Burrow
oNocturnal Pruritus
oHistory of Pruritus in family members
oHistory of contact with a scabies patient
and/or
•Microscopic Demonstration of mite, eggs, or faecal pellets
Exclusion Criteria
The following patients will be excluded from the study:
•Patients with Crusted or Nodular Scabies
•Patients with Diabetes Mellitus
• Known cases of allergy to any ingredient of study medication
•History of Addiction (alcohol, drugs)
•Known cases of hepatic, renal or cardiac ailments
•Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of Jarab (Scabies)Timepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessmentTimepoint: 2 weeks